356 related articles for article (PubMed ID: 24134931)
21. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma.
So JS; Epstein JI
Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157
[TBL] [Abstract][Full Text] [Related]
22. Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviour.
Lopez Beltran A; Montironi R; Cheng L
Histopathology; 2014 May; 64(6):872-9. PubMed ID: 24321001
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.
Downes MR; Torlakovic EE; Aldaoud N; Zlotta AR; Evans AJ; van der Kwast TH
J Clin Pathol; 2013 Sep; 66(9):779-86. PubMed ID: 23775437
[TBL] [Abstract][Full Text] [Related]
24. [Urothelial carcinoma of the navicular fossa].
Kurimoto S; Kitamura T; Kuji H; Ueki T; Moriyama N; Tajima A; Aso Y
Urologe A; 1996 May; 35(3):251-3. PubMed ID: 8711833
[TBL] [Abstract][Full Text] [Related]
25. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
Bruch PG; Plage H; Hofbauer S; Kornienko K; Weinberger S; Roßner F; Schallenberg S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Zecha H; Klatte T; Schlomm T; Horst D; Elezkurtaj S
Exp Mol Pathol; 2023 Jun; 131():104860. PubMed ID: 36997051
[TBL] [Abstract][Full Text] [Related]
26. Strong androgen receptor expression is not useful in distinguishing GATA3 + metastases.
Lionti S; La Rocca L; Nunnari CM; Barresi V
Pathol Res Pract; 2018 Dec; 214(12):2110-2114. PubMed ID: 30293951
[TBL] [Abstract][Full Text] [Related]
27. Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
Makboul R; Refaiy A; Abdelkawi IF; Hameed DA; Elderwy AA; Shalaby MM; Merseburger AS; Hussein MR
Pathol Res Pract; 2016 May; 212(5):385-92. PubMed ID: 26916953
[TBL] [Abstract][Full Text] [Related]
28. Value of GATA3 immunostaining in tumor diagnosis: a review.
Ordóñez NG
Adv Anat Pathol; 2013 Sep; 20(5):352-60. PubMed ID: 23939152
[TBL] [Abstract][Full Text] [Related]
29. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.
Chang A; Brimo F; Montgomery EA; Epstein JI
Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625
[TBL] [Abstract][Full Text] [Related]
30. Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas.
Clark BZ; Beriwal S; Dabbs DJ; Bhargava R
Am J Clin Pathol; 2014 Jul; 142(1):64-71. PubMed ID: 24926087
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.
Owens SR; Greenson JK
Am J Surg Pathol; 2007 Feb; 31(2):285-90. PubMed ID: 17255774
[TBL] [Abstract][Full Text] [Related]
32. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series.
Raspollini MR; Sardi I; Giunti L; Di Lollo S; Baroni G; Stomaci N; Menghetti I; Franchi A
Hum Pathol; 2011 Aug; 42(8):1149-58. PubMed ID: 21334719
[TBL] [Abstract][Full Text] [Related]
33. Carcinoma of the urethra.
Zhang M; Adeniran AJ; Vikram R; Tamboli P; Pettaway C; Bondaruk J; Liu J; Baggerly K; Czerniak B
Hum Pathol; 2018 Feb; 72():35-44. PubMed ID: 28827100
[TBL] [Abstract][Full Text] [Related]
34. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
[TBL] [Abstract][Full Text] [Related]
35. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
37. GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin.
Bezerra SM; Lotan TL; Faraj SF; Karram S; Sharma R; Schoenberg M; Bivalacqua TJ; Netto GJ
Hum Pathol; 2014 Aug; 45(8):1682-7. PubMed ID: 24925221
[TBL] [Abstract][Full Text] [Related]
38. Utility of uroplakin II expression as a marker of urothelial carcinoma.
Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological features of carcinoma of the distal penile urethra.
Corbishley CM; Rajab RM; Watkin NA
Semin Diagn Pathol; 2015 May; 32(3):238-44. PubMed ID: 25656527
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.
Sikic D; Keck B; Wach S; Taubert H; Wullich B; Goebell PJ; Kahlmeyer A; Olbert P; Isfort P; Nimphius W; Hartmann A; Giedl J;
PLoS One; 2017; 12(6):e0179602. PubMed ID: 28632777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
